Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.75 | 1.36 |
NAV | ₹303.35 | ₹203.53 |
Fund Started | 01 Aug 2005 | 07 May 2007 |
Fund Size | ₹12101.13 Cr | ₹89383.23 Cr |
Exit Load | Exit load of 1% if redeemed less than 1 year | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -2.74% | 5.94% |
3 Year | 15.69% | 24.58% |
5 Year | 19.03% | 26.08% |
1 Year
3 Year
5 Year
Equity | 98.45% | 93.94% |
Cash | 1.54% | 6.06% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Polycab India Ltd. | 2.57% |
The Phoenix Mills Ltd. | 2.36% |
Persistent Systems Ltd. | 2.22% |
Indian Bank | 2.13% |
Max Financial Services Ltd. | 2.08% |
Coforge Ltd. | 2.02% |
The Federal Bank Ltd. | 1.96% |
Tube Investments Of India Ltd. | 1.87% |
Schaeffler India Ltd. | 1.75% |
JK Cement Ltd. | 1.72% |
Name | Assets |
|---|---|
Max Financial Services Ltd. | 4.46% |
AU Small Finance Bank Ltd. | 3.70% |
Indian Bank | 3.54% |
The Federal Bank Ltd. | 3.38% |
Balkrishna Industries Ltd. | 3.37% |
Fortis Healthcare Ltd. | 3.19% |
Coforge Ltd. | 3.11% |
Hindustan Petroleum Corporation Ltd. | 2.96% |
Glenmark Pharmaceuticals Ltd. | 2.67% |
Ipca Laboratories Ltd. | 2.52% |
Name | Vishal Chopda | Chirag Setalvad |
Start Date | 02 May 2022 | 28 Jun 2014 |
Name
Start Date
Description | The scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of mid cap companies. | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. |
Launch Date | 01 Aug 2005 | 07 May 2007 |
Description
Launch Date